AXITILIENT Trademark

Trademark Overview

On Wednesday, May 25, 2016, a trademark application was filed for AXITILIENT with the United States Patent and Trademark Office. The USPTO has given the AXITILIENT trademark a serial number of 87049630. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, March 17, 2020. This trademark is owned by Pfizer Inc.. The AXITILIENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
axitilient

General Information

Serial Number87049630
Word MarkAXITILIENT
Filing DateWednesday, May 25, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, March 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 2, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, May 18, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 18, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, September 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2019EXTENSION 5 GRANTED
Tuesday, September 10, 2019EXTENSION 5 FILED
Thursday, September 12, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 10, 2019TEAS EXTENSION RECEIVED
Monday, September 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 14, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, February 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 21, 2019EXTENSION 4 GRANTED
Thursday, February 21, 2019EXTENSION 4 FILED
Thursday, February 21, 2019TEAS EXTENSION RECEIVED
Wednesday, August 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 20, 2018EXTENSION 3 GRANTED
Monday, August 20, 2018EXTENSION 3 FILED
Monday, August 20, 2018TEAS EXTENSION RECEIVED
Saturday, February 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2018EXTENSION 2 GRANTED
Thursday, February 8, 2018EXTENSION 2 FILED
Thursday, February 8, 2018TEAS EXTENSION RECEIVED
Tuesday, August 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 28, 2017EXTENSION 1 GRANTED
Friday, July 28, 2017EXTENSION 1 FILED
Friday, July 28, 2017TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 12, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 6, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 6, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 30, 2016ASSIGNED TO LIE
Wednesday, November 9, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, July 24, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, July 24, 2016NON-FINAL ACTION E-MAILED
Sunday, July 24, 2016NON-FINAL ACTION WRITTEN
Thursday, July 21, 2016ASSIGNED TO EXAMINER
Thursday, June 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 28, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

axitilient preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases